Co-administration of interleukin-3 mutant polypeptides with...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/20 (2006.01) A61K 38/18 (2006.01) A61K 38/19 (2006.01) A61K 38/27 (2006.01) C07K 14/54 (2006.01)

Patent

CA 2182474

The present invention relates to human interleukin-3 (hIL-3) variant or mutant proteins (muteins) functionally co-administered with other colony stimulating factors (CSF), cytokines, lymphokines, interleukins, hematopoietic growth factors or IL-3 variants.

Cette invention concerne des protéines mutantes ou variantes d'interleukine-3 humaine (mutéines) administrées de manière fonctionnelle conjointement avec d'autres facteurs stimulant les colonies (CSF), cytokines, lymphokines, interleukines, facteurs de croissance hématopoïetiques ou variants de IL-3.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Co-administration of interleukin-3 mutant polypeptides with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Co-administration of interleukin-3 mutant polypeptides with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Co-administration of interleukin-3 mutant polypeptides with... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1689089

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.